California Medical Association
CMA Member Help Center
On November 8, 2016, California voters approved state ballot initiative Proposition 64, “The Control, Regulate and Tax Adult Use of Marijuana Act” (AUMA), which legalized the use of recreational marijuana for those 21 years of age and older. AUMA’s passage follows earlier state efforts to regulate medical marijuana: in 1996, California’s Proposition 215 decriminalized the cultivation and use of cannabis by seriously ill individuals upon a physician’s recommendation. In 2004, the Medical Marijuana Program Act enacted an identification card program to achieve greater consistency in the application of Proposition 215. More recently, in 2015, California enacted three bills that created the Medical Marijuana Regulation and Safety Act, which seeks to establish a comprehensive regulatory framework for commercial medical marijuana by January 1, 2018.
This webinar will cover the new state requirements under AUMA and present the most current clinical information pertaining to the potential medical uses of cannabis as well as its medico-legal policy context. Data will mainly be pulled from recent meta-analyses and systematic reviews from the past two to five years. The webinar will explicitly focus on whether or not evidence exists, and how strong any evidence is, for the use of cannabis to treat symptoms from a handful of diseases with particular focus on chronic and neuropathic pain.
This webinar is free to CMA members ($99 for non-members).
Samantha Pellón, MPH, is an Associate Director in CMA’s Center for Health Policy. She covers public health policy issues and staffs CMA’s Council on Science and Public Health, a committee composed of physicians and medical students charged to study and make recommendations concerning public health and clinical issues.
Michael Lubrano, M.D., MPH, is a postgraduate anesthesia resident in UCSF Medical Center’s Department of Anesthesia and Perioperative Care. He recently served two terms as chair of CMA’s Resident and Fellow Section (RFS) and is a currently both a member of the RFS Delegation to the CMA House of Delegates, as well as a member of CMA’s Council on Science and Public Health. Dr. Lubrano has an interest in the public health consequences of cannabis legalization, as well as its potential use for chronic pain management.
Webinar Notice: Please register at least one hour before the webinar. If you do not register an hour before the webinar start time, we cannot guarantee your attendance. Questions: 800-786-4CMA (4262)